KU 271 (Oxybutynin chloride extended-release 10 mg)

Pill imprint KU 271 has been identified as Oxybutynin chloride extended-release 10 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for KU 271

Oxybutynin chloride extended-release 10 mg KU 271
Oxybutynin chloride extended-release 10 mg KU 271
Oxybutynin chloride extended-release
Imprint:
KU
271
Strength:
10 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Kremers Urban
National Drug Code (NDC):
62175-0271
Inactive Ingredients:
lactose anhydrous
lactose monohydrate
mannitol
dextrose, anhydrous
tartaric acid
silicon dioxide
magnesium stearate
cellulose acetate
polyethylene glycol 400
titanium dioxide
ferrosoferric oxide
propylene glycol
hypromellose 2208 (100 mPa.s)
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)